Low expression of β-arrestin 1, but not β-arrestin 2, in GH- and PRL-secreting pituitary tumors correlates with a reduced recycling rate of SSTR2 and better SS analogs response in terms of GH suppression, both in vitro and in vivo (67). This evidence concerns the gene PRL and pituitary tumor.